Cardiomyocyte proliferation
Cardiomyocyte Proliferation
Cardiomyocyte proliferation refers to the process by which cardiomyocytes, or heart muscle cells, increase in number through cell division. This process is crucial for heart development during embryonic and early postnatal life. However, the capacity for cardiomyocyte proliferation significantly decreases in adult mammals, including humans, which limits the heart's ability to regenerate after injury.
Overview[edit | edit source]
Cardiomyocytes, also known as cardiac myocytes, are the muscle cells that make up the cardiac muscle tissue in the heart. These cells are responsible for the heart's contractile function, which enables it to pump blood throughout the body. During embryonic development, cardiomyocytes proliferate rapidly to form the heart. However, shortly after birth, the majority of cardiomyocytes exit the cell cycle, meaning they no longer divide and proliferate.
Regulation of Cardiomyocyte Proliferation[edit | edit source]
The regulation of cardiomyocyte proliferation is complex and involves multiple signaling pathways and factors. Some of the key regulators include cyclin-dependent kinases (CDKs), cyclins, and cyclin-dependent kinase inhibitors (CKIs). These molecules regulate the cell cycle and determine whether a cell will enter the S phase, where DNA replication occurs, and subsequently divide.
Cardiomyocyte Proliferation and Heart Regeneration[edit | edit source]
The limited ability of adult cardiomyocytes to proliferate is a major barrier to heart regeneration following injury, such as a myocardial infarction (heart attack). This is because the lost cardiomyocytes are largely replaced by scar tissue, which impairs the heart's function. Therefore, understanding the mechanisms that regulate cardiomyocyte proliferation could lead to new therapeutic strategies for promoting heart regeneration.
Research and Future Directions[edit | edit source]
Research in this field is focused on understanding the molecular mechanisms that regulate cardiomyocyte proliferation and identifying ways to stimulate this process in adult hearts. Some promising approaches include manipulating signaling pathways, using small molecules to stimulate cardiomyocyte proliferation, and using stem cells to generate new cardiomyocytes.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD